Kamihira Osamu, Hattori Ryohei, Yamaguchi Akito, Kawa Gen, Ogawa Osamu, Habuchi Tomonori, Kawauchi Akihiro, Uozumi Jiro, Yokoi Shigeaki, Tsujihata Masao, Hasui Yoshihiro, Miyakoda Keiko, Tada Harue, Ono Yoshinari, Naito Seiji
Department of Urology, Komaki City Hospital, Komaki, Aichi, Japan.
Eur Urol. 2009 Jun;55(6):1397-407. doi: 10.1016/j.eururo.2009.03.003. Epub 2009 Mar 10.
Laparoscopic nephroureterectomy (LNUx) is prevalent in Japan and throughout the world, but long-term outcome data remain limited.
To understand the present state of LNUx in Japan, we conducted a multicenter analysis of clinical outcome and long-term cancer control for patients who underwent the procedure.
DESIGN, SETTING, AND PARTICIPANTS: Between January 1995 and December 2005, 1003 patients with urothelial cancer in the upper urinary tract were treated with LNUx at 51 institutions in Japan, and patient data were collected retrospectively.
Patient profiles were gathered and analyzed for survival, intravesical recurrence, and risk factors influencing them.
Median operative time was 320 min. Median bleeding volume was 232 ml. Complications occurred in 93 cases (9.3%) intraoperatively and in 107 cases (10.7%) postoperatively. Overall survival rate was 70% at 5 yr. Grade 3, pT3 or pT4, multifocal tumor, lymph-node metastasis, and previous or coexistent bladder tumor were independent risk factors for overall survival. Intravesical recurrence rate was 43% at 5 yr. Intravesical recurrence occurred more frequently in males, in patients with multifocal tumors, in patients with previous or coexistent bladder tumors, and in patients who underwent the hand-assisted approach.
Our report represents the largest multicenter analysis of LNUx reported to date. Male sex and the use of the hand-assisted approach were shown for the first time to be risk factors for recurrence-free survival and intravesical recurrence. To further analyze the effectiveness of LNUx, a long-term outcome comparison with risk stratification must be made between LNUx and open nephroureterectomy.
腹腔镜肾输尿管切除术(LNUx)在日本及全球都很普遍,但长期疗效数据仍然有限。
为了解日本LNUx的现状,我们对接受该手术的患者的临床结局和长期癌症控制情况进行了多中心分析。
设计、地点和参与者:1995年1月至2005年12月期间,日本51家机构对1003例上尿路尿路上皮癌患者进行了LNUx治疗,并对患者数据进行了回顾性收集。
收集患者资料并分析生存情况、膀胱内复发情况以及影响这些情况的危险因素。
中位手术时间为320分钟。中位出血量为232毫升。术中并发症发生93例(9.3%),术后发生107例(10.7%)。5年总生存率为70%。3级、pT3或pT4、多灶性肿瘤、淋巴结转移以及既往或并存膀胱肿瘤是总生存的独立危险因素。5年膀胱内复发率为43%。膀胱内复发在男性、多灶性肿瘤患者、既往或并存膀胱肿瘤患者以及接受手辅助入路的患者中更常见。
我们的报告是迄今为止报道的关于LNUx的最大规模多中心分析。首次表明男性和使用手辅助入路是无复发生存和膀胱内复发的危险因素。为进一步分析LNUx的有效性,必须对LNUx与开放性肾输尿管切除术进行长期疗效比较并进行风险分层。